One Team Report

Overview

The report presents Suzuken Group's FY2024 performance for the April 2024-March 2025 period and its transition toward a health creation enterprise. It highlights consolidated net sales of 2,399,952 million yen, 12,923 Group employees, and Scope 1+2 emissions of 71,082 t-CO2. Sustainability priorities include reducing pharmaceutical waste, developing human capital, and climate action, including a 40% Scope 1 and 2 reduction target by FY2030 and a carbon-neutral pledge by 2050. The report also describes Board oversight of Group-wide sustainability activities.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: 1 April 2024 – 31 March 2025
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services